[
  {
    "ts": null,
    "headline": "S&P 500 Gains & Losses Today: Index Snaps Winning Streak Ahead of Fed Meeting",
    "summary": "The S&P 500 slipped 0.6% on Monday, May 5, 2025, breaking a nine-day winning streak ahead of this week's interest-rate decision by the Federal Open Market Committee.",
    "url": "https://finnhub.io/api/news?id=c7eb1d0a56f2ed6134980af76a4f0ecdce121e7d6fdcd0e9f093df2712380c18",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746480587,
      "headline": "S&P 500 Gains & Losses Today: Index Snaps Winning Streak Ahead of Fed Meeting",
      "id": 134267069,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "The S&P 500 slipped 0.6% on Monday, May 5, 2025, breaking a nine-day winning streak ahead of this week's interest-rate decision by the Federal Open Market Committee.",
      "url": "https://finnhub.io/api/news?id=c7eb1d0a56f2ed6134980af76a4f0ecdce121e7d6fdcd0e9f093df2712380c18"
    }
  },
  {
    "ts": null,
    "headline": "Why Zimmer Biomet (ZBH) Stock Is Trading Lower Today",
    "summary": "Shares of medical device company Zimmer Biomet (NYSE:ZBH) fell 10.2% in the afternoon session after the company reported underwhelming first quarter 2025 results as it lowered its full-year EPS guidance. A key takeaway was the weak growth. Sales were up just 1% as demand for some product lines came in weaker. While hips and trauma gear did well, others, like bone cement and surgical tools, dropped nearly 5%. Overall, this was a softer quarter.",
    "url": "https://finnhub.io/api/news?id=10e649dff60e089a0830e23067ab0db2542b88387d44763536c7c8ed15ff1f27",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746465999,
      "headline": "Why Zimmer Biomet (ZBH) Stock Is Trading Lower Today",
      "id": 134267070,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Shares of medical device company Zimmer Biomet (NYSE:ZBH) fell 10.2% in the afternoon session after the company reported underwhelming first quarter 2025 results as it lowered its full-year EPS guidance. A key takeaway was the weak growth. Sales were up just 1% as demand for some product lines came in weaker. While hips and trauma gear did well, others, like bone cement and surgical tools, dropped nearly 5%. Overall, this was a softer quarter.",
      "url": "https://finnhub.io/api/news?id=10e649dff60e089a0830e23067ab0db2542b88387d44763536c7c8ed15ff1f27"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Q1 Earnings Beat, Operating Margin Dips, Stock Down in Premarket",
    "summary": "Zimmer Biomet reports solid first-quarter performance across its geographic regions. However, contraction in its operating margin is a concern.",
    "url": "https://finnhub.io/api/news?id=dee3973ffd9e537004183a1b7172ebfed96844186ce908a48cf06fefbdfea561",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746464340,
      "headline": "ZBH Q1 Earnings Beat, Operating Margin Dips, Stock Down in Premarket",
      "id": 134267071,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet reports solid first-quarter performance across its geographic regions. However, contraction in its operating margin is a concern.",
      "url": "https://finnhub.io/api/news?id=dee3973ffd9e537004183a1b7172ebfed96844186ce908a48cf06fefbdfea561"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
    "summary": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=29826e486858b7d2baafde540842dccbc82858e1f32089ac2c7af87beadcbd08",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746462600,
      "headline": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
      "id": 134283736,
      "image": "",
      "related": "ZBH",
      "source": "MarketWatch",
      "summary": "Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=29826e486858b7d2baafde540842dccbc82858e1f32089ac2c7af87beadcbd08"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer (ZBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates",
    "summary": "While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=43c882617eba11b45be8e2d95a238ecbd2f939e60cee8c35a6055a173049c059",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746451809,
      "headline": "Zimmer (ZBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates",
      "id": 134247593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=43c882617eba11b45be8e2d95a238ecbd2f939e60cee8c35a6055a173049c059"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Q1 2025 Earnings Call Transcript",
    "summary": "Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ETCompany ParticipantsDavid DeMartino - SVP, IRIvan Tornos -...",
    "url": "https://finnhub.io/api/news?id=27222a85df97a1075f922cc366e00fdb412a01a05502cf2df9338c1989034980",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746446719,
      "headline": "Zimmer Biomet Holdings, Inc. (ZBH) Q1 2025 Earnings Call Transcript",
      "id": 134248777,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "ZBH",
      "source": "SeekingAlpha",
      "summary": "Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ETCompany ParticipantsDavid DeMartino - SVP, IRIvan Tornos -...",
      "url": "https://finnhub.io/api/news?id=27222a85df97a1075f922cc366e00fdb412a01a05502cf2df9338c1989034980"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty",
    "summary": "Earlier this year, Zimmer said that it would acquire medical device firm Paragon 28 for $1.1 billion, to expand its portfolio of orthopedic surgical devices.  Zimmer expects 2025 adjusted profit per share in the range of $7.90 to $8.10, compared with its prior view of $8.15 to $8.35 per share.  Analysts were expecting annual profit of $8.19 per share, according to data compiled by LSEG.",
    "url": "https://finnhub.io/api/news?id=69255670bf7166e81ab6e4eb45b31156252859b83d4a00755f25465fd1b5e47b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746445204,
      "headline": "Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty",
      "id": 134247594,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Earlier this year, Zimmer said that it would acquire medical device firm Paragon 28 for $1.1 billion, to expand its portfolio of orthopedic surgical devices.  Zimmer expects 2025 adjusted profit per share in the range of $7.90 to $8.10, compared with its prior view of $8.15 to $8.35 per share.  Analysts were expecting annual profit of $8.19 per share, according to data compiled by LSEG.",
      "url": "https://finnhub.io/api/news?id=69255670bf7166e81ab6e4eb45b31156252859b83d4a00755f25465fd1b5e47b"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet (ZBH) Surpasses Q1 Earnings and Revenue Estimates",
    "summary": "Zimmer (ZBH) delivered earnings and revenue surprises of 2.84% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=4b206fb87b533d7bee5cb3a2b7fdb22328c29e94214917c0c8a2ebbf965d838c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746445203,
      "headline": "Zimmer Biomet (ZBH) Surpasses Q1 Earnings and Revenue Estimates",
      "id": 134247485,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer (ZBH) delivered earnings and revenue surprises of 2.84% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=4b206fb87b533d7bee5cb3a2b7fdb22328c29e94214917c0c8a2ebbf965d838c"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet lowers 2025 profit forecast amid tariff uncertainty, shares fall",
    "summary": "Zimmer Biomet Holdings onMonday lowered its 2025 adjusted profit forecast, and said itexpects the proposed trade tariffs to weigh on the company'searnings this year. The Warsaw,...",
    "url": "https://finnhub.io/api/news?id=4b00aa4bb797ec9f19c910eb7083618109078f54c47d36e76ef208a202a0ee3c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746444853,
      "headline": "Zimmer Biomet lowers 2025 profit forecast amid tariff uncertainty, shares fall",
      "id": 134247838,
      "image": "",
      "related": "ZBH",
      "source": "Finnhub",
      "summary": "Zimmer Biomet Holdings onMonday lowered its 2025 adjusted profit forecast, and said itexpects the proposed trade tariffs to weigh on the company'searnings this year. The Warsaw,...",
      "url": "https://finnhub.io/api/news?id=4b00aa4bb797ec9f19c910eb7083618109078f54c47d36e76ef208a202a0ee3c"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet (NYSE:ZBH) Posts Better-Than-Expected Sales In Q1",
    "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q1 CY2025, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=f8e3740e9525d2a24a70397d22625abdc5a0e463d923ba0098c804b5d1d625b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746442111,
      "headline": "Zimmer Biomet (NYSE:ZBH) Posts Better-Than-Expected Sales In Q1",
      "id": 134247596,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q1 CY2025, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=f8e3740e9525d2a24a70397d22625abdc5a0e463d923ba0098c804b5d1d625b2"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer: Q1 Earnings Snapshot",
    "summary": "The results surpassed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.76 per share. The orthopedic device maker posted revenue of $1.91 billion in the period, also surpassing Street forecasts.",
    "url": "https://finnhub.io/api/news?id=8558e1d32e2754b1293254caf3d8cdbc0e9c5d0bcb74a27ac4b2ae89acd762ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746441312,
      "headline": "Zimmer: Q1 Earnings Snapshot",
      "id": 134247597,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "The results surpassed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.76 per share. The orthopedic device maker posted revenue of $1.91 billion in the period, also surpassing Street forecasts.",
      "url": "https://finnhub.io/api/news?id=8558e1d32e2754b1293254caf3d8cdbc0e9c5d0bcb74a27ac4b2ae89acd762ee"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Announces First Quarter 2025 Financial Results",
    "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2025. The Company reported first quarter net sales of $1.909 billion, an increase of 1.1% over the prior year period, and an increase of 2.3% on a constant currency1 basis. Net earnings for the first quarter were $182.0 million, or $361.1 million on an adjusted1 basis.",
    "url": "https://finnhub.io/api/news?id=4c93ec29adb402c40011e3f3a7c98e04fcdef88af1e754ca41f8d90ece8bfd68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746441000,
      "headline": "Zimmer Biomet Announces First Quarter 2025 Financial Results",
      "id": 134247598,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2025. The Company reported first quarter net sales of $1.909 billion, an increase of 1.1% over the prior year period, and an increase of 2.3% on a constant currency1 basis. Net earnings for the first quarter were $182.0 million, or $361.1 million on an adjusted1 basis.",
      "url": "https://finnhub.io/api/news?id=4c93ec29adb402c40011e3f3a7c98e04fcdef88af1e754ca41f8d90ece8bfd68"
    }
  },
  {
    "ts": null,
    "headline": "Zimmer Biomet Gives Mixed Outlook Update Over Currency Shifts, Tariffs",
    "summary": "Zimmer Biomet Gives Mixed Outlook Update Over Currency Shifts, Tariffs",
    "url": "https://finnhub.io/api/news?id=e887d8da835c46f24db4611f790ba88100fa552421e675ba60d49a5e28987db2",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746427800,
      "headline": "Zimmer Biomet Gives Mixed Outlook Update Over Currency Shifts, Tariffs",
      "id": 134283737,
      "image": "",
      "related": "ZBH",
      "source": "MarketWatch",
      "summary": "Zimmer Biomet Gives Mixed Outlook Update Over Currency Shifts, Tariffs",
      "url": "https://finnhub.io/api/news?id=e887d8da835c46f24db4611f790ba88100fa552421e675ba60d49a5e28987db2"
    }
  }
]